Literature DB >> 23644725

ABC Schizophrenia study: an overview of results since 1996.

H Häfner1, K Maurer, W an der Heiden.   

Abstract

PURPOSE: The ABC Schizophrenia study, led by a single research team, investigated a schizophrenia sample systematically over quarter of a century. This paper summarises results from 1996 onwards. The initial goals were to explain the considerably higher age at first admission in women, and to obtain precise information on the onset and early course of schizophrenia as a prerequisite for early intervention.
METHOD: The study was hypothesis-driven. People with schizophrenia were compared in the prodrome and at first admission to those with unipolar depression and to healthy controls. We analysed the medium-term (5-year) and the long-term (12-year) course of schizophrenia, its symptom dimensions, social parameters and predictors. SAMPLES: (1) 276 population-based first admissions (232 first episodes) of schizophrenia (age range 12-59 years); (2) a subsample of 130 first admissions for schizophrenia; (3) 130 first admissions for unipolar depression; (4) 130 healthy population controls and (5) 1,109 consecutive first admissions for schizophrenia spectrum disorder without an age limit.
RESULTS: The prodromal stages of schizophrenia and depression were very similar until positive symptoms appeared. The most frequent symptom in schizophrenia was depressed mood. The course of psychosis from prodrome to 12 years following first admission was very variable. From 5 to 12 years after first admission the course was characterised by irregular exacerbations of the main symptom dimensions, with no overall deterioration or improvement.
CONCLUSIONS: Schizophrenic psychosis and severe affective disorder, rather than representing discrete illnesses, probably mark different stages in the manifestation of psychopathology produced by various degrees of brain dysfunction.

Entities:  

Mesh:

Year:  2013        PMID: 23644725     DOI: 10.1007/s00127-013-0700-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  38 in total

1.  Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle.

Authors:  H Häfner; M Hambrecht; W Löffler; P Munk-Jørgensen; A Riecher-Rössler
Journal:  Psychol Med       Date:  1998-03       Impact factor: 7.723

Review 2.  [Schizophrenia and depression].

Authors:  K Maurer; G Trendler; M Schmidt; W An der Heiden; R Könnecke; H Häfner
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

3.  Early detection of schizophrenia: current evidence and future perspectives.

Authors:  Heinz Häfner; Kurt Maurer
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

4.  [Schizophrenia and delusions in middle aged and elderly patients. Epidemiology and etiological hypothesis].

Authors:  H Häfner; W Löffler; A Riecher-Rössler; W Häfner-Ranabauer
Journal:  Nervenarzt       Date:  2001-05       Impact factor: 1.214

5.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

6.  Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?

Authors:  Heinz Häfner; Wolfram an der Heiden; Kurt Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

Review 7.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

8.  First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences.

Authors:  H Häfner; A Riecher-Rössler; K Maurer; B Fätkenheuer; W Löffler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

9.  Duration of psychosis and outcome in first-episode schizophrenia.

Authors:  A D Loebel; J A Lieberman; J M Alvir; D I Mayerhoff; S H Geisler; S R Szymanski
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

10.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

View more
  31 in total

1.  The distribution of self-reported psychotic-like experiences in non-psychotic help-seeking mental health patients in the general population; a factor mixture analysis.

Authors:  Judith Rietdijk; Marjolein Fokkema; Daniel Stahl; Lucia Valmaggia; Helga K Ising; Sara Dragt; Rianne M C Klaassen; Dorien H Nieman; Rachel Loewy; Pim Cuijpers; Philippe Delespaul; Don H Linszen; Mark van der Gaag
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-10-15       Impact factor: 4.328

Review 2.  Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Authors:  Hendrik Müller; Sonja Laier; Andreas Bechdolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

3.  Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.

Authors:  Berend Malchow; Katriona Keller; Alkomiet Hasan; Sebastian Dörfler; Thomas Schneider-Axmann; Ursula Hillmer-Vogel; William G Honer; Thomas G Schulze; Andree Niklas; Thomas Wobrock; Andrea Schmitt; Peter Falkai
Journal:  Schizophr Bull       Date:  2015-03-17       Impact factor: 9.306

4.  On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification.

Authors:  Rachel N Pläschke; Edna C Cieslik; Veronika I Müller; Felix Hoffstaedter; Anna Plachti; Deepthi P Varikuti; Mareike Goosses; Anne Latz; Svenja Caspers; Christiane Jockwitz; Susanne Moebus; Oliver Gruber; Claudia R Eickhoff; Kathrin Reetz; Julia Heller; Martin Südmeyer; Christian Mathys; Julian Caspers; Christian Grefkes; Tobias Kalenscher; Robert Langner; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2017-09-06       Impact factor: 5.038

5.  Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.

Authors:  Kristin M Healey; David L Penn; Diana Perkins; Scott W Woods; Richard S E Keefe; Jean Addington
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

6.  What is schizophrenia? 25 years of research into schizophrenia - the Age Beginning Course Study.

Authors:  Heinz Häfner
Journal:  World J Psychiatry       Date:  2015-06-22

7.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

8.  Prevalence of schizophrenia and related disorders in Malaga (Spain): results using multiple clinical databases.

Authors:  B Moreno-Küstner; F Mayoral; D Navas-Campaña; J M García-Herrera; P Angona; C Martín; F Rivas
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-15       Impact factor: 6.892

Review 9.  NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?

Authors:  Joseph C Masdeu; Josep Dalmau; Karen F Berman
Journal:  Trends Neurosci       Date:  2016-04-26       Impact factor: 13.837

10.  Testing trait depression as a potential clinical domain in schizophrenia.

Authors:  Joshua Chiappelli; Peter Kochunov; Katherine DeRiso; Kavita Thangavelu; Hemalatha Sampath; Florian Muellerklein; Katie L Nugent; Teodor T Postolache; William T Carpenter; L Elliot Hong
Journal:  Schizophr Res       Date:  2014-08-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.